STOCK TITAN

[Form 4] NeuroBo Pharmaceuticals, Inc. Common Stock Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Woodworth Marshall H, listed as Chief Financial Officer, reported a Form 4 for MetaVia Inc. (MTVA) showing a transaction dated 08/12/2025. The filing records a transaction code G and shows acquisition of 14,200 shares at a price of $0, bringing his beneficial ownership to 30,079 shares. The Form 4 was executed by a power of attorney on 08/13/2025 and includes Exhibit 24 (Power of Attorney).

Woodworth Marshall H, indicato come Chief Financial Officer, ha dichiarato un Form 4 per MetaVia Inc. (MTVA) relativo a una transazione datata 08/12/2025. La comunicazione riporta il codice di transazione G e indica l'acquisto di 14,200 azioni a un prezzo di $0, portando la sua partecipazione effettiva a 30,079 azioni. Il Form 4 è stato eseguito tramite procura il 08/13/2025 e include l'Allegato 24 (Procura).

Woodworth Marshall H, registrado como Chief Financial Officer, informó un Form 4 de MetaVia Inc. (MTVA) que muestra una transacción con fecha 08/12/2025. El documento refleja el código de transacción G y la adquisición de 14,200 acciones a un precio de $0, elevando su participación beneficiaria a 30,079 acciones. El Form 4 fue ejecutado mediante poder el 08/13/2025 e incluye el Anexo 24 (Poder).

Woodworth Marshall H는 최고재무책임자(Chief Financial Officer)로 등재된 상태에서 MetaVia Inc. (MTVA)에 대한 Form 4를 보고했으며, 해당 서류에는 08/12/2025자 거래가 표시되어 있습니다. 제출서류에는 거래 코드 G가 기재되어 있고, 가격 $014,200주를 취득한 것으로 나타나 그의 실질적 보유 주식 수가 30,079주로 늘어났습니다. 이 Form 4는 08/13/2025에 위임장을 통해 실행되었으며 Exhibit 24(위임장)를 포함하고 있습니다.

Woodworth Marshall H, inscrit comme Chief Financial Officer, a déclaré un Form 4 pour MetaVia Inc. (MTVA) indiquant une opération datée du 08/12/2025. Le dossier enregistre un code de transaction G et mentionne l'acquisition de 14,200 actions au prix de $0, portant sa participation bénéficiaire à 30,079 actions. Le Form 4 a été signé par procuration le 08/13/2025 et comprend l'Exhibit 24 (Procuration).

Woodworth Marshall H, aufgeführt als Chief Financial Officer, meldete ein Form 4 für MetaVia Inc. (MTVA), das eine Transaktion vom 08/12/2025 ausweist. Die Einreichung verzeichnet den Transaktionscode G und zeigt den Erwerb von 14,200 Aktien zu einem Preis von $0, wodurch sein wirtschaftliches Eigentum auf 30,079 Aktien ansteigt. Das Form 4 wurde am 08/13/2025 mittels einer Vollmacht ausgeführt und enthält Anlage 24 (Vollmacht).

Positive
  • Insider increased ownership: CFO reported acquisition of 14,200 shares, raising direct beneficial ownership to 30,079 shares
Negative
  • None.

Insights

TL;DR: Insider filing shows a material insider increase in shareholdings, but the transaction details limit valuation conclusions.

The Form 4 discloses a reported acquisition of 14,200 common shares by the company's CFO, increasing direct beneficial ownership to 30,079 shares. The transaction is coded as "G" and reported with a price of $0, which restricts interpretation of whether this was a grant, gift, or other non-cash transfer. For market impact, the absolute share count is modest and further context on outstanding shares or recent insider activity would determine materiality.

TL;DR: Filing is procedurally complete but the "G" code and $0 price require clarity for governance assessment.

The report is filed under Section 16 and includes a Power of Attorney signature, indicating compliance with filing procedures. The transaction code "G" and a reported price of $0 suggest a non-standard transfer type; governance implications depend on the nature of the transfer (e.g., gift, grant). Without explicit explanation of the transaction type and any related agreements, it is difficult to assess conflict-of-interest or compensation governance implications.

Woodworth Marshall H, indicato come Chief Financial Officer, ha dichiarato un Form 4 per MetaVia Inc. (MTVA) relativo a una transazione datata 08/12/2025. La comunicazione riporta il codice di transazione G e indica l'acquisto di 14,200 azioni a un prezzo di $0, portando la sua partecipazione effettiva a 30,079 azioni. Il Form 4 è stato eseguito tramite procura il 08/13/2025 e include l'Allegato 24 (Procura).

Woodworth Marshall H, registrado como Chief Financial Officer, informó un Form 4 de MetaVia Inc. (MTVA) que muestra una transacción con fecha 08/12/2025. El documento refleja el código de transacción G y la adquisición de 14,200 acciones a un precio de $0, elevando su participación beneficiaria a 30,079 acciones. El Form 4 fue ejecutado mediante poder el 08/13/2025 e incluye el Anexo 24 (Poder).

Woodworth Marshall H는 최고재무책임자(Chief Financial Officer)로 등재된 상태에서 MetaVia Inc. (MTVA)에 대한 Form 4를 보고했으며, 해당 서류에는 08/12/2025자 거래가 표시되어 있습니다. 제출서류에는 거래 코드 G가 기재되어 있고, 가격 $014,200주를 취득한 것으로 나타나 그의 실질적 보유 주식 수가 30,079주로 늘어났습니다. 이 Form 4는 08/13/2025에 위임장을 통해 실행되었으며 Exhibit 24(위임장)를 포함하고 있습니다.

Woodworth Marshall H, inscrit comme Chief Financial Officer, a déclaré un Form 4 pour MetaVia Inc. (MTVA) indiquant une opération datée du 08/12/2025. Le dossier enregistre un code de transaction G et mentionne l'acquisition de 14,200 actions au prix de $0, portant sa participation bénéficiaire à 30,079 actions. Le Form 4 a été signé par procuration le 08/13/2025 et comprend l'Exhibit 24 (Procuration).

Woodworth Marshall H, aufgeführt als Chief Financial Officer, meldete ein Form 4 für MetaVia Inc. (MTVA), das eine Transaktion vom 08/12/2025 ausweist. Die Einreichung verzeichnet den Transaktionscode G und zeigt den Erwerb von 14,200 Aktien zu einem Preis von $0, wodurch sein wirtschaftliches Eigentum auf 30,079 Aktien ansteigt. Das Form 4 wurde am 08/13/2025 mittels einer Vollmacht ausgeführt und enthält Anlage 24 (Vollmacht).

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Woodworth Marshall H

(Last) (First) (Middle)
C/O METAVIA INC.
545 CONCORD AVENUE, SUITE 210

(Street)
CAMBRIDGE MA 02138

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MetaVia Inc. [ MTVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/12/2025 G 14,200 D $0 30,079 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24: Power of Attorney is attached.
/s/ Phillip D. Torrence, by Power of Attorney 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did the MetaVia (MTVA) Form 4 filed by Woodworth Marshall H report?

The Form 4 reports a transaction dated 08/12/2025 in which Woodworth Marshall H is shown with a transaction code G, acquiring 14,200 common shares and holding 30,079 shares after the transaction.

What price was reported for the shares in the MTVA Form 4?

The filing shows a reported price of $0 for the transaction in the Form 4.

What is Woodworth Marshall H's role at MetaVia noted in the filing?

The Form 4 identifies Woodworth Marshall H as an Officer with the title Chief Financial Officer.

When was the Form 4 signed or executed?

The signature block shows the form was executed by a power of attorney and dated 08/13/2025.

Does the filing include supporting exhibits?

Yes, the Form 4 notes Exhibit 24: Power of Attorney is attached.
Neurobo Pharmaceuticals Inc

NASDAQ:NRBO

NRBO Rankings

NRBO Latest News

NRBO Latest SEC Filings

NRBO Stock Data

20.33M
3.00M
65.24%
12.71%
0.4%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE